Manufacturer record
BDR Pharmaceuticals Intl Pvt. Ltd. Vanseti: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by BDR Pharmaceuticals Intl Pvt. Ltd. Vanseti was declared Not of Standard Quality in November 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: BI240239A, Ferric Carboxymaltose Injection 50 mg/ml (exp Nov 2026). CDL, Kolkata (CDSCO lab) found it not of standard quality: The sample does not conform to Manufacturer Specification with respect to the Test of Particulate matter. Listed in the November 2025 alert.
Records by type
1 record linked to BDR Pharmaceuticals Intl Pvt. Ltd. Vanseti in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ferric Carboxymaltose Injection 50 mg/ml | Batch BI240239AMfg Dec 2024 · Exp Nov 2026 | The sample does not conform to Manufacturer Specification with respect to the Test of Particulate matterParticulate matter | CDL, KolkataCDSCO lab | Nov 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.